Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1993 Jan;67(1):589-92.
doi: 10.1128/JVI.67.1.589-592.1993.

Theiler's virus infection of beta 2-microglobulin-deficient mice

Affiliations

Theiler's virus infection of beta 2-microglobulin-deficient mice

L Fiette et al. J Virol. 1993 Jan.

Abstract

Theiler's virus, a murine picornavirus, persists in the central nervous systems of susceptible mice and induces a chronic demyelinating disease. Susceptibility or resistance to this disease is controlled in part by the H2-D locus of the major histocompatibility complex (MHC). For this reason, it has been proposed that CD8+ class I-restricted cytotoxic T cells play a main role in the pathogenesis of this viral infection. We recently reported the existence of anti-virus CD8+ cytotoxic T cells in the course of Theiler's virus infection. In the present study, we examined the role of these effector cells in mice in which the beta 2-microglobulin gene had been disrupted. These mice fail to express class I MHC molecules and therefore lack CD8+ T cells. The mice are derived from a C57BL/6 x 129/Ola cross and are H-2b, a haplotype associated with resistance to Theiler's virus infection. beta 2-Microglobulin-deficient mice (beta 2m-/-mice) failed to clear the virus, developed demyelination, and, interestingly, did not succumb to early infection. These results demonstrate that CD8+ T cells are required to clear Theiler's virus infection. In contrast with a current hypothesis, they also demonstrate that CD8+ T cells are not major mediators of the demyelinating disease.

PubMed Disclaimer

References

    1. Proc Natl Acad Sci U S A. 1984 Sep;81(17):5445-8 - PubMed
    1. Infect Immun. 1977 Mar;15(3):903-9 - PubMed
    1. J Virol. 1986 Mar;57(3):992-7 - PubMed
    1. Eur J Immunol. 1986 May;16(5):551-7 - PubMed
    1. Neurology. 1986 Jul;36(7):964-70 - PubMed

Publication types

LinkOut - more resources